Siyaram Silk Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 18, 2025, 6:40 pm

Competitors of Siyaram Silk Mills Ltd

All Competitor Stocks of Siyaram Silk Mills Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:25 am

Below is a detailed analysis of the quarterly data for Siyaram Silk Mills Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 388.50 Cr.. The value appears to be declining and may need further review. It has decreased from 736.08 Cr. (Mar 2025) to 388.50 Cr., marking a decrease of 347.58 Cr..
• For Expenses, as of Jun 2025, the value is 367.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 624.42 Cr. (Mar 2025) to 367.82 Cr., marking a decrease of 256.60 Cr..
• For Operating Profit, as of Jun 2025, the value is 20.68 Cr.. The value appears to be declining and may need further review. It has decreased from 111.66 Cr. (Mar 2025) to 20.68 Cr., marking a decrease of 90.98 Cr..
• For OPM %, as of Jun 2025, the value is 5.32%. The value appears to be declining and may need further review. It has decreased from 15.17% (Mar 2025) to 5.32%, marking a decrease of 9.85%.
• For Other Income, as of Jun 2025, the value is 11.96 Cr.. The value appears to be declining and may need further review. It has decreased from 13.59 Cr. (Mar 2025) to 11.96 Cr., marking a decrease of 1.63 Cr..
• For Interest, as of Jun 2025, the value is 6.45 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.59 Cr. (Mar 2025) to 6.45 Cr., marking a decrease of 1.14 Cr..
• For Depreciation, as of Jun 2025, the value is 19.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.51 Cr. (Mar 2025) to 19.82 Cr., marking an increase of 2.31 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.37 Cr.. The value appears to be declining and may need further review. It has decreased from 100.15 Cr. (Mar 2025) to 6.37 Cr., marking a decrease of 93.78 Cr..
• For Tax %, as of Jun 2025, the value is 27.79%. The value appears to be increasing, which may not be favorable. It has increased from 27.65% (Mar 2025) to 27.79%, marking an increase of 0.14%.
• For Net Profit, as of Jun 2025, the value is 4.60 Cr.. The value appears to be declining and may need further review. It has decreased from 72.45 Cr. (Mar 2025) to 4.60 Cr., marking a decrease of 67.85 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.01. The value appears to be declining and may need further review. It has decreased from 15.97 (Mar 2025) to 1.01, marking a decrease of 14.96.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:25 am

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: May 13, 2025, 2:42 pm

Below is a detailed analysis of the balance sheet data for Siyaram Silk Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,279.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,132.00 Cr. (Mar 2024) to 1,279.00 Cr., marking an increase of 147.00 Cr..
• For Borrowings, as of Mar 2025, the value is 262.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 175.00 Cr. (Mar 2024) to 262.00 Cr., marking an increase of 87.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 342.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 290.00 Cr. (Mar 2024) to 342.00 Cr., marking an increase of 52.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,893.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,606.00 Cr. (Mar 2024) to 1,893.00 Cr., marking an increase of 287.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 589.00 Cr.. The value appears strong and on an upward trend. It has increased from 474.00 Cr. (Mar 2024) to 589.00 Cr., marking an increase of 115.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 16.00 Cr..
• For Investments, as of Mar 2025, the value is 218.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2024) to 218.00 Cr., marking an increase of 177.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,083.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,072.00 Cr. (Mar 2024) to 1,083.00 Cr., marking an increase of 11.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,893.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,606.00 Cr. (Mar 2024) to 1,893.00 Cr., marking an increase of 287.00 Cr..

Notably, the Reserves (1,279.00 Cr.) exceed the Borrowings (262.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Siyaram Silk Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 43.45. This value is within the healthy range. It has increased from 39.99 (Mar 24) to 43.45, marking an increase of 3.46.
• For Diluted EPS (Rs.), as of Mar 25, the value is 43.45. This value is within the healthy range. It has increased from 39.99 (Mar 24) to 43.45, marking an increase of 3.46.
• For Cash EPS (Rs.), as of Mar 25, the value is 56.73. This value is within the healthy range. It has increased from 52.93 (Mar 24) to 56.73, marking an increase of 3.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 282.81. It has increased from 250.61 (Mar 24) to 282.81, marking an increase of 32.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 282.81. It has increased from 250.61 (Mar 24) to 282.81, marking an increase of 32.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 489.67. It has increased from 461.11 (Mar 24) to 489.67, marking an increase of 28.56.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 77.44. This value is within the healthy range. It has increased from 71.16 (Mar 24) to 77.44, marking an increase of 6.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is 64.16. This value is within the healthy range. It has increased from 58.95 (Mar 24) to 64.16, marking an increase of 5.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 58.92. This value is within the healthy range. It has increased from 54.47 (Mar 24) to 58.92, marking an increase of 4.45.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 43.45. This value is within the healthy range. It has increased from 40.72 (Mar 24) to 43.45, marking an increase of 2.73.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 43.45. This value is within the healthy range. It has increased from 40.72 (Mar 24) to 43.45, marking an increase of 2.73.
• For PBDIT Margin (%), as of Mar 25, the value is 15.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 15.81, marking an increase of 0.38.
• For PBIT Margin (%), as of Mar 25, the value is 13.10. This value is within the healthy range. It has increased from 12.78 (Mar 24) to 13.10, marking an increase of 0.32.
• For PBT Margin (%), as of Mar 25, the value is 12.03. This value is within the healthy range. It has increased from 11.81 (Mar 24) to 12.03, marking an increase of 0.22.
• For Net Profit Margin (%), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 8.83 (Mar 24) to 8.87, marking an increase of 0.04.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 8.83 (Mar 24) to 8.87, marking an increase of 0.04.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.36. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 15.36, marking a decrease of 0.88.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.65. This value is within the healthy range. It has decreased from 22.11 (Mar 24) to 20.65, marking a decrease of 1.46.
• For Return On Assets (%), as of Mar 25, the value is 10.44. This value is within the healthy range. It has decreased from 11.53 (Mar 24) to 10.44, marking a decrease of 1.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.18. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.18, marking an increase of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.27. It has decreased from 1.29 (Mar 24) to 1.27, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.64. This value is within the healthy range. It has decreased from 2.73 (Mar 24) to 2.64, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has increased from 1.54 (Mar 24) to 1.74, marking an increase of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.94. This value is within the healthy range. It has increased from 1.91 (Mar 24) to 4.94, marking an increase of 3.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.31. This value is within the healthy range. It has decreased from 27.33 (Mar 24) to 25.31, marking a decrease of 2.02.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.39. This value is below the healthy minimum of 20. It has decreased from 21.03 (Mar 24) to 19.39, marking a decrease of 1.64.
• For Earning Retention Ratio (%), as of Mar 25, the value is 74.69. This value exceeds the healthy maximum of 70. It has increased from 72.67 (Mar 24) to 74.69, marking an increase of 2.02.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.61. This value exceeds the healthy maximum of 70. It has increased from 78.97 (Mar 24) to 80.61, marking an increase of 1.64.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 14.78. This value is within the healthy range. It has decreased from 15.91 (Mar 24) to 14.78, marking a decrease of 1.13.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 10.10 (Mar 24) to 9.29, marking a decrease of 0.81.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,189.83. It has increased from 2,132.14 (Mar 24) to 3,189.83, marking an increase of 1,057.69.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.44, marking an increase of 0.42.
• For EV / EBITDA (X), as of Mar 25, the value is 9.08. This value is within the healthy range. It has increased from 6.60 (Mar 24) to 9.08, marking an increase of 2.48.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 1.33, marking an increase of 0.39.
• For Retention Ratios (%), as of Mar 25, the value is 74.68. This value exceeds the healthy maximum of 70. It has increased from 72.66 (Mar 24) to 74.68, marking an increase of 2.02.
• For Price / BV (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.74 (Mar 24) to 2.31, marking an increase of 0.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 1.33, marking an increase of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness